JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB122898

Anti-p53 (phospho S46) antibody [36]

Be the first to review this product! 리뷰 제출

|

(6 제품이 사용된 논문 )

Mouse Monoclonal P53 phospho S46 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Synthetic Peptide within Human TP53 phospho S46.

대체 명칭 보기

P53, TP53, Cellular tumor antigen p53, Antigen NY-CO-13, Phosphoprotein p53, Tumor suppressor p53

2 이미지
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p53 (phospho S46) antibody [36] (AB122898)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p53 (phospho S46) antibody [36] (AB122898)

Immunohistochemical analysis of p53 (phospho S46) expression in paraffin emebdded formalin fixed Human stomach cancer section using ab122898.

Western blot - Anti-p53 (phospho S46) antibody [36] (AB122898)
  • WB

Unknown

Western blot - Anti-p53 (phospho S46) antibody [36] (AB122898)

The lower panel is the whole p53 protein identified by omnipotent anti-p53 antibody.

All lanes:

Western blot - Anti-p53 (phospho S46) antibody [36] (ab122898) at 1/1000 dilution

Lane 1:

Crude cell extracts of MOLT4, untreated

Lane 2:

Crude cell extracts of MOLT4, treated with adriamycin (ADR) for 24 h

Predicted band size: 43 kDa

false

주요 정보

Host species

Mouse

Clonality

Monoclonal

Clone number

36

Isotype

IgG1

Light chain 타입

kappa

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

Synthetic Peptide within Human TP53 phospho S46. The exact immunogen used to generate this antibody is proprietary information.

P04637

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/2000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Ion exchange chromatography
Purification 관련 사항
ab122898 is the purified IgG fraction obtained from serum free culture of mouse hybridoma.
보관 버퍼
pH: 6 - 8.5 Constituents: PBS, 50% Glycerol (glycerin, glycerine)
배송 시 보관 조건
Blue Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

The protein p53 also known as TP53 or tumor protein p53 has a molecular weight of approximately 53 kDa. It acts as a transcription factor and plays a major role in cell cycle regulation apoptosis and maintaining genomic stability. This protein mainly expresses in the nucleus of cells and acts as a critical regulator of cellular responses to stress signals including DNA damage. Scientists commonly use p53 antibodies in various assays like western blot and p53 immunofluorescence to detect and study its expression and functional status in cells.
Biological function summary

P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.

Pathways

P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.

P53 mutation or inactivation is often associated with the development of cancer given its role in controlling cell division and preventing tumor formation. Specifically its dysfunction has been linked to cancers such as breast cancer and lung cancer. Additionally p53 can interact with other mutant proteins like Ras compounding mutations that contribute to tumor progression and aggressive cancer phenotypes. Understanding these interactions and the status of p53 can be important in developing targeted cancer therapies.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 35618207, PubMed : 36634798, PubMed : 38653238, PubMed : 9840937). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17189187, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 38653238, PubMed : 9840937). Negatively regulates cell division by controlling expression of a set of genes required for this process (PubMed : 11025664, PubMed : 12524540, PubMed : 12810724, PubMed : 15186775, PubMed : 15340061, PubMed : 17317671, PubMed : 17349958, PubMed : 19556538, PubMed : 20673990, PubMed : 20959462, PubMed : 22726440, PubMed : 24051492, PubMed : 24652652, PubMed : 9840937). One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression (PubMed : 12524540, PubMed : 17189187). Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed : 12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed : 12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed : 24051492).
See full target information TP53 phospho S46

제품이 사용된 논문 (6)

Recent publications for all applications. Explore the 전체 목록 and refine your search

BMC cancer 24:25 PubMed38166895

2024

Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qinsong Liu,Yong Yuan,Xiaofen Shang,Lu Xin

Microsystems & nanoengineering 6:94 PubMed34567704

2020

Rapid micro-immunohistochemistry.

Applications

Unspecified application

Species

Unspecified reactive species

Robert D Lovchik,David Taylor,Govind Kaigala

Genes & development 30:918-30 PubMed27034505

2016

An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew Jennis,Che-Pei Kung,Subhasree Basu,Anna Budina-Kolomets,Julia I-Ju Leu,Sakina Khaku,Jeremy P Scott,Kathy Q Cai,Michelle R Campbell,Devin K Porter,Xuting Wang,Douglas A Bell,Xiaoxian Li,David S Garlick,Qin Liu,Monica Hollstein,Donna L George,Maureen E Murphy

Molecular and cellular biology 30:1620-33 PubMed20123963

2010

Requirement of ATM for rapid p53 phosphorylation at Ser46 without Ser/Thr-Gln sequences.

Applications

Unspecified application

Species

Unspecified reactive species

Masami Kodama,Chihiro Otsubo,Toru Hirota,Jun Yokota,Masato Enari,Yoichi Taya

The Journal of biological chemistry 285:4909-19 PubMed19965871

2009

ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.

Applications

Unspecified application

Species

Unspecified reactive species

Naoe Taira,Hiroyuki Yamamoto,Tomoko Yamaguchi,Yoshio Miki,Kiyotsugu Yoshida

Molecular cell 25:725-38 PubMed17349958

2007

DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage.

Applications

Unspecified application

Species

Unspecified reactive species

Naoe Taira,Keishi Nihira,Tomoko Yamaguchi,Yoshio Miki,Kiyotsugu Yoshida
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com